66 related articles for article (PubMed ID: 19193505)
1. Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function.
Hsiao SM; Chang SR
J Formos Med Assoc; 2024 Jun; 123(6):710-715. PubMed ID: 38092655
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials.
Sun F; Geng S; Wang H; Wang H; Liu Z; Wang X; Li T; Wan W; Lu L; Teng X; Morel L; Ye S
Lupus Sci Med; 2020 Oct; 7(1):. PubMed ID: 33093216
[TBL] [Abstract][Full Text] [Related]
3. Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case-control study.
Mok CC; Cheung CCL; Chan KL; Tse SM; To CH
Rheumatology (Oxford); 2023 Nov; ():. PubMed ID: 37947324
[TBL] [Abstract][Full Text] [Related]
4. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
5. Sex Hormones in Acquired Immunity and Autoimmune Disease.
Moulton VR
Front Immunol; 2018; 9():2279. PubMed ID: 30337927
[TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
[TBL] [Abstract][Full Text] [Related]
7. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.
Hughes GC; Choubey D
Nat Rev Rheumatol; 2014 Dec; 10(12):740-51. PubMed ID: 25155581
[TBL] [Abstract][Full Text] [Related]
8. Progesterone and autoimmune disease.
Hughes GC
Autoimmun Rev; 2012 May; 11(6-7):A502-14. PubMed ID: 22193289
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus and hormone replacement therapy.
Gompel A; Piette JC
Menopause Int; 2007 Jun; 13(2):65-70. PubMed ID: 17540136
[TBL] [Abstract][Full Text] [Related]
10. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
11. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
13. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
14. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
[TBL] [Abstract][Full Text] [Related]
15. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]